Clinical trials
Relatives clinical trials
Below are recruiting relatives clinical trials, each written for real people, not researchers. We’re tracking 2,011 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05681975Recruiting
Test whether antibodies relate to food reaction symptoms
This study looks at adults who have symptoms they believe are caused by reactions to foods. Researchers will test immune blood markers (antibodies) to better understand what may be driving these symptoms and whether that information could help people in the future.
MadridAges 18–80 - NCT05694039Recruiting
Track thinking changes in older adults with hearing loss
This study follows older adults who have age-related hearing loss to see whether wearing hearing aids helps protect thinking and memory over time. You may be included if your hearing loss is the type that hearing aids can usually improve and if your thinking test scores suggest mild cognitive difficulties.
Guangzhou, GuangdongAges 60–85 - NCT05723445Recruiting
Low glycemic diet test for diabetes and body changes in CF
This trial studies whether a low glycemic load (a specific way of choosing carbohydrates) improves blood sugar control and body composition in adults with cystic fibrosis–related diabetes. It may help reduce blood sugar problems and support healthier weight and body measurements.
Boston, MassachusettsAges 18–70 - NCT05726396RecruitingPhase 2
Microbiome therapy for steroid-resistant immune colitis
This Phase 2 pilot study tests a “restorative microbiota therapy” (RMT) to treat colitis caused by immune checkpoint inhibitors when standard treatments like steroids are not working. It aims to see if this approach is safe and practical, and may improve diarrhea and gut inflammation.
Brainerd, MinnesotaAges 18 years+ - NCT05732051RecruitingPhase 2
Nicotinamide riboside to protect the heart during breast cancer chemo
This trial tests whether nicotinamide riboside can help prevent heart problems caused by a common breast-cancer chemotherapy (anthracyclines). If you’re eligible, you’ll be followed to see how your heart is doing during treatment.
Lørenskog, AkershusAges 18 years+ - NCT05754190Recruiting
Smartphone study of mood and symptoms in people with pain
This study uses a smartphone app to track daily pain and mood changes over about 4 months. It’s meant to learn patterns that could help better understand how mood and pain affect each other.
Providence, Rhode IslandAges 18 years+ - NCT05786924RecruitingPhase 1/Phase 2
Targeted cancer drug study for RAS/RAF mutation-positive tumors
This Phase 1/2 study tests S241656 (a targeted cancer medicine) in people whose cancers have certain “RAS/RAF” gene changes. It may help shrink tumors or control cancer growth, and also finds the safest dose and best way to use the drug.
Gilbert, ArizonaAges 18 years+ - NCT05803785RecruitingPhase 1
Safety study of an injection for wet macular degeneration
This Phase 1 trial tests whether BBC1501, an injection given into the eye, is safe for people with wet age-related macular degeneration (nAMD). It mainly looks at side effects and whether the study injections can be given safely in patients who still have active disease despite prior anti-VEGF treatments.
Sydney, New South WalesAges 50 years+ - NCT05845255Recruiting
Test wearable monitoring for epilepsy quality of life and safety
This study tests a wearable device that records seizure-related information to understand how epilepsy affects daily life and safety. It may help your care team better track seizures in real-world settings and understand quality-of-life changes.
KorkAges 12–65 - NCT05910580Recruiting
Screening and support for alcohol and substance risk in adults
This study aims to improve care access and outcomes for adults who screen positive for risky alcohol or drug use. If you qualify, you may be offered ways to connect to support during your reproductive years.
Boston, MassachusettsAges 18 years+ - NCT06022016Recruiting
Family study for DDX41 gene and blood cancer risk
This study looks at families where a blood cancer (hemopathy) may be linked to a change in the DDX41 gene. It tests family members to see if they have the same gene change, which can help understand hereditary risks.
BordeauxAges 18 years+ - NCT06046118Recruiting
Light therapy for dry age-related macular degeneration
This trial tests whether a special light treatment (photobiomodulation) can help people with dry age-related macular degeneration (AMD). It is designed for those with early to moderate dry AMD who still have fairly good vision.
ParisAges 50 years+ - NCT06072651Recruiting
Mother-Baby study on motivation for babies
This study looks at what babies find motivating during play. It helps researchers understand how babies respond to different rewards.
Ann Arbor, MichiganAges birth+ - NCT06087458RecruitingPhase 1/Phase 2
Study of VOY-101 for advanced dry age-related macular degeneration
This trial is testing a new treatment called VOY-101 for people with advanced dry age-related macular degeneration (geographic atrophy). It aims to see if the drug can slow or stop vision loss in this condition.
Scottsdale, ArizonaAges 60 years+ - NCT06132035RecruitingPhase 1
CG-P5 eye drops for wet macular degeneration
This study tests a new eye drop (CG-P5) for people with wet age-related macular degeneration. It aims to see if the drops are safe and may help improve vision.
Manchester, ConnecticutAges 50 years+ - NCT06149351Recruiting
Saliva test for concussion diagnosis
This study is testing if saliva samples can help doctors diagnose concussions more quickly and accurately. It is open to men in France who may help improve concussion care.
MontpellierAges 18–50 - NCT06157151RecruitingPhase 2
New drug plus pembrolizumab for advanced cervical cancer
This trial tests a new experimental drug, PRGN-2009, combined with the immunotherapy pembrolizumab (Keytruda) for people with HPV-related cervical cancer that has come back or spread. It is for those who have already tried pembrolizumab and are looking for another option.
Little Rock, ArkansasAges 18 years+ - NCT06202027Recruiting
CRYSVITA safety and effectiveness in Korean patients
This study looks at the safety and effectiveness of CRYSVITA (burosumab) in real-world use among patients in South Korea. If you are already prescribed CRYSVITA for X-linked hypophosphatemia, your doctor may ask you to join this survey to help track how well it works and any side effects.
Wŏnju, Gangwon-doAges 1 day+ - NCT06248073Recruiting
Online program and task training for Parkinson's disease
This study tests an online program and task-based training to help people with mild Parkinson's disease improve their movement and reaching ability. It is designed for people who can still sit and reach for objects without major tremors or other health problems.
Linkou DistrictAges 45–70 - NCT06305676Recruiting
A study for early detection of HPV throat cancer
This study looks for early signs of HPV-related throat cancer. If you've just been diagnosed and haven't started treatment, your blood or saliva samples may help improve future screening tests.
Tampa, FloridaAges 18 years+ - NCT06309342Recruiting
Study for inactive adults aged 40 to prevent lifestyle-related disorders
This trial looks at whether certain physical tests can help prevent conditions caused by an inactive lifestyle. It's designed for people who are 40 years old and not very active physically.
Mölnlycke, Region Västra GötalandAges 39–40 - NCT06310486Recruiting
Emergency call study on drowning
This trial looks at emergency calls for drowning incidents to see how the call is handled and what happens to the patient. If you or someone you care for had a drowning and emergency services were called, you may be able to join.
NæstvedAges Any age - NCT06322238RecruitingPhase 2
Can a DNA test help prevent drug side effects in primary care?
This study tests whether a cheek-swab DNA test can help doctors choose safer medicines for you. If you are starting a new drug in primary care, you might join to help prevent side effects.
Rochester, MinnesotaAges 18 years+ - NCT06324149Recruiting
Frailty and aging conditions in chronic diseases
This study looks at how frailty affects the course of chronic diseases and how chronic diseases affect frailty. It may help understand aging-related conditions better.
MilanAges 18–100
Hear when a new Relatives trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for relatives?
- Yes. Clin2 currently lists 2,011 recruiting relatives studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a relatives trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a relatives trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.